[WATCH NOW: The Biggest Products And Innovations For Partners At AWS re:Invent 2025] Additionally, the Seattle-based world ...
Data from a phase 2 trial of Roche's oral BTK inhibitor fenebrutinib have shown "near-complete suppression" of disease activity and disability progression in relapsing multiple sclerosis (MS). The ...
A 2020 spinout of Seattle's Pioneer Square Labs, SecureSave was co-founded by CEO Devin Miller, CTO Bassam Saliba, and TV ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback